BSA Nanoparticles for siRNA Delivery: Coating Effects on Nanoparticle Properties, Plasma Protein Adsorption, andIn VitrosiRNA Delivery

Abstract

Developing vehicles for the delivery of therapeutic molecules, like siRNA, is an area of active research. Nanoparticles composed of bovine serum albumin, stabilized via the adsorption of poly-L-lysine (PLL), have been shown to be potentially inert drug-delivery vehicles. With the primary goal of reducing nonspecific protein adsorption, the effect of using comb-type structures of poly(ethylene glycol) (1 kDa, PEG) units conjugated to PLL (4.2 and 24 kDa) on BSA-NP properties, apparent siRNA release rate, cell viability, and cell uptake were evaluated. PEGylated PLL coatings resulted in NPs with ζ-potentials close to neutral. Incubation with platelet-poor plasma showed the composition of the adsorbed proteome was similar for all systems. siRNA was effectively encapsulated and released in a sustained manner from all NPs. With 4.2 kDa PLL, cellular uptake was not affected by the presence of PEG, but PEG coating inhibited uptake with 24 kDa PLL NPs. Moreover, 24 kDa PLL systems were cytotoxic and this cytotoxicity was diminished upon PEG incorporation. The overall results identified a BSA-NP coating structure that provided effective siRNA encapsulation while reducing ζ-potential, protein adsorption, and cytotoxicity, necessary attributes for in vivo application of drug-delivery vehicles.

Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy

“…However, liposomes have not been the only platform used for delivering siRNA. Polymeric micelles [542][543][544][545][546], polymer conjugates [547][548][549][550], and polymeric nanoparticles [551][552][553][554][555][556][557] have also shown promising efficacy as non-viral carriers for the delivery of siRNAs in the treatment of different diseases.…”

Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs

“…The capacity to interact and condensate negatively charged RNAs, the ease by which they can be synthesized, and their tunable physicochemical properties have made cationic peptides a widely used carrier for oligonucleotides [ 58 ]. Cationic peptides have been exploited in different approaches, such as direct conjugation to RNA strands, noncovalent complexation with negatively charged oligonucleotides, and use as adjuvants in polymeric or lipidic carriers [ 59 ].…”

Fabrication, Characterization, and in Vitro Evaluation of Pegylated Glyceride Labrasol® Nanostructured Lipid Carrier Composites of Methotrexate: The Pathway to Effective Cancer Therapy

“…3Ac) with their PDI of 0.15±0.02, 0.21±0.04, and 0.24±0.01, respectively. The increase in PS and PDI in case of Labrasol ® MTX-NLC in comparison to olive oil MTX-NLC may be attributed due to the presence of PEG moieties in Labrasol ® which could be extended to the particle surface, leading to increase in particle growth or PS [39]. Surface charge or zeta potential of all the formulations was observed as negative, −18.4±4.8 mV (blank NLC), −24.7±22 mV (olive oil MTX NLC), and −28.5±77 mV (Labrasol ® MTX NLC).…”